rs9357155

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_148919.4(PSMB8):​c.537+63C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 1,611,412 control chromosomes in the GnomAD database, including 12,384 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1037 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11347 hom. )

Consequence

PSMB8
NM_148919.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0980

Publications

80 publications found
Variant links:
Genes affected
PSMB8 (HGNC:9545): (proteasome 20S subunit beta 8) The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. [provided by RefSeq, Jul 2008]
PSMB8 Gene-Disease associations (from GenCC):
  • proteasome-associated autoinflammatory syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • proteosome-associated autoinflammatory syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 6-32842071-G-A is Benign according to our data. Variant chr6-32842071-G-A is described in ClinVar as Benign. ClinVar VariationId is 1277080.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.16 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSMB8NM_148919.4 linkc.537+63C>T intron_variant Intron 4 of 5 ENST00000374882.8 NP_683720.2 P28062-1X5CMJ9
PSMB8NM_004159.5 linkc.525+63C>T intron_variant Intron 4 of 5 NP_004150.1 P28062-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSMB8ENST00000374882.8 linkc.537+63C>T intron_variant Intron 4 of 5 1 NM_148919.4 ENSP00000364016.4 P28062-1

Frequencies

GnomAD3 genomes
AF:
0.112
AC:
17011
AN:
152084
Hom.:
1037
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0760
Gnomad AMI
AF:
0.174
Gnomad AMR
AF:
0.140
Gnomad ASJ
AF:
0.0836
Gnomad EAS
AF:
0.162
Gnomad SAS
AF:
0.169
Gnomad FIN
AF:
0.122
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.119
Gnomad OTH
AF:
0.0965
GnomAD4 exome
AF:
0.122
AC:
177891
AN:
1459210
Hom.:
11347
Cov.:
33
AF XY:
0.122
AC XY:
88695
AN XY:
726046
show subpopulations
African (AFR)
AF:
0.0746
AC:
2495
AN:
33462
American (AMR)
AF:
0.184
AC:
8207
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.0879
AC:
2296
AN:
26126
East Asian (EAS)
AF:
0.140
AC:
5564
AN:
39690
South Asian (SAS)
AF:
0.143
AC:
12362
AN:
86214
European-Finnish (FIN)
AF:
0.123
AC:
6410
AN:
52300
Middle Eastern (MID)
AF:
0.0973
AC:
544
AN:
5590
European-Non Finnish (NFE)
AF:
0.120
AC:
133005
AN:
1110806
Other (OTH)
AF:
0.116
AC:
7008
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
9298
18595
27893
37190
46488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4924
9848
14772
19696
24620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.112
AC:
17007
AN:
152202
Hom.:
1037
Cov.:
32
AF XY:
0.113
AC XY:
8425
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0759
AC:
3152
AN:
41538
American (AMR)
AF:
0.140
AC:
2142
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0836
AC:
290
AN:
3470
East Asian (EAS)
AF:
0.162
AC:
838
AN:
5182
South Asian (SAS)
AF:
0.169
AC:
816
AN:
4822
European-Finnish (FIN)
AF:
0.122
AC:
1292
AN:
10596
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.119
AC:
8087
AN:
67986
Other (OTH)
AF:
0.0945
AC:
200
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
780
1560
2341
3121
3901
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
202
404
606
808
1010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.119
Hom.:
4739
Bravo
AF:
0.111
Asia WGS
AF:
0.112
AC:
389
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 14, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 22% of patients studied by a panel of primary immunodeficiencies. Number of patients: 21. Only high quality variants are reported. -

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.6
DANN
Benign
0.38
PhyloP100
-0.098
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9357155; hg19: chr6-32809848; COSMIC: COSV62755469; COSMIC: COSV62755469; API